Josh Lieberman, MD, PhD @MolMicro_Path

Assistant Director, Molecular Diagnosis Section, Microbiology Laboratory, UWMC in Seattle. ID Pathology, Mol Micro, testing pathways.|Tweets are my own views. Seattle, WA Joined June 2020

Tweets

558
Followers

240
Following

134
Likes

625

Sean Murphy @WeFightMalaria

3 years ago

Best wishes and great thanks to Mark Chandler, who retired from the UW Dept of Microbiology on Wednesday. I’m forever grateful for Mark’s partnership in the UW MICRO460 Parasitology course. Thanks for all you’ve done for UW students over the years!

0 1 3 0 0

Download Image

Josh Lieberman, MD, PhD @MolMicro_Path

3 years ago

Interested in Leishmania genomics and POC assay development? I’m looking for an RS3 or RS2 with a molecular biology/NGS background; bioinformatics experience a plus. Apply via UW Hires RS3 bit.ly/3BLjVvx RS2 bit.ly/3UErpa8

0 0 0 0 0

Erin McCreary @ErinMcCreary

3 years ago

“data” is a plural noun.

10 3 47 0 0

Josh Lieberman, MD, PhD @MolMicro_Path

3 years ago

Interested in leishmaniasis and its epidemiology in the US? @uwlabmedpath did most of the Leish testing in the US from 9/21 - 7/22. Come chat with me about what we found at @ASTMH #TropMed22! Poster session A, LB-5103. Monday, 10/31.

0 2 4 0 1

Ade Adamson, MD MPP @AdeAdamson

3 years ago

Another provocative study by @JoannElmoreMD et al showing that dermatopathologists are influenced by the diagnosis of a previous dermatopathologist. This can even influence them to make an INCORRECT melanoma diagnosis. jamanetwork.com/journals/jamad…

5 34 98 0 19

Download Image

Prof Peter Hotez MD PhD DSc(hon) @PeterHotez

3 years ago

1/3 We already know that Sen Paul has no interest in covering the origins of Covid, it’s all about using his power in the Senate to target 🎯 prominent US scientists, while inviting fringe elements to testify and promote outlandish conspiracies foxnews.com/politics/rand-…

150 375 1K 0 33

Susan Butler-Wu, ☮️PhD, D(ABMM) @SBtotheDub

3 years ago

There are no commercial tests for monkeypox in the US - only lab-developed tests (LDTs). LDTs essential for large labs to adapt & pivot as we learn more about tropism including need to test non-lesion specimens. This is precisely why the #VALIDAct would be so problematic.

1 5 18 0 0

Josh Lieberman, MD, PhD @MolMicro_Path

3 years ago

Great thread for #clinicalmicrobiologists

Susan Butler-Wu, ☮️PhD, D(ABMM) @SBtotheDub

3 years ago

Great thread for #clinicalmicrobiologists

3 13 40 0 3

Download Gif

0 0 0 0 0

Josh Lieberman, MD, PhD @MolMicro_Path

3 years ago

Great interview on an critical, under-the-radar topic. I've heard #VALID justified "FDA sent warning letters *to XYZ labs*" but this confusing lab regulation with #LDT regulation. Requiring #FDA approval of LDTs does NOT prevent malfeasance, fraud, bad lab mgmt, poor compliance